Infofin | ULB

Universitï¿½ Libre de Bruxelles

Liste des projets

Recherche de projets

S'enregistrer

Connexion

Description de l’appel

Programme :	Asahi Kansei Pharma Open Innovation
Organisation :	Asahi Kansei Pharma
Deadline :	28/02/2022 - Full-proposal
Deadline2 :
Type d'information :	Financement
Type de programme :	Appels à projets de recherche fondamentale/ou de base (hors financement de l’Union Européenne), Transfert technologique et valorisation de la recherche
Description courte :	”ASAHI KASEI PHARMA OPEN INNOVATION” is an open innovation platform started in 2018 to recruit candidates for research collaborations related to drug discovery. We aim to create innovative new drugs to match our corporate philosophy, ”contribute to life and living for people around the world”. Realizing this goal requires the combined power of many researchers, both internal and external to the company, providing innovation through the integration of their knowledge.
Description complète :	Requested programs: 1. Autoimmune Diseases 2. Critical Care Medicine 3. Neurodegenerative Diseases 4. Pain and Neuropathy 5. Bone Diseases 6. Drug Discovery Platform Technology The research will be conducted over a period of 1–3 years, depending on the research content. Milestones will be set for each year, and the content of the research will be reviewed as needed based on the research results. After the end of the joint research period under this program, the joint research may be continued or expanded depending on the research results. The ownership of inventions, etc., generated during the course of the collaboration will be determined in accordance with the inventor principle, and a joint or independent application with our company will be considered. We may ask you to purchase, establish preferential negotiation rights, or license intellectual property rights related to the collaboration. In this research collaboration, priority will be given to securing intellectual property rights (patent applications) depending on the content of the research. For this reason, we may ask you to proceed to research on practical applications without publishing results for a certain period after the contract ends. In addition, we will request notification before you submit a presentation to an academic conference or publish a research paper to discuss the contents and timing of your presentation or publication.
Critères d’admission/attribution :	The proposals to be adopted will be selected based on a comprehensive evaluation of conformity to the requested topics, originality and usefulness of research proposed, research plan viability, and conflict with Asahi Kasei Pharma internal projects. Review and selection of proposals will be conducted at a meeting of Asahi Kasei Pharma research specialists.
Financement :	50,000–200,000 USD (per project, per year) (including overhead costs, excluding tax) Depending on the research content and stage, we will determine the research expenses based on the research plan agreed upon by both parties.
Pour postuler / aide du Département Recherche :	- Download application documents and fill in the required information. - Access the “Provisional registration form” within the application form and enter the necessary information. - When you have completed the provisional registration, a URL for the main registration will be sent to your registered email address. - At the URL for main registration, enter the required information and upload your application documents. - When you receive notification that registration is complete at your registered email address, the application procedure is complete. - Application period: 5:00AM , Jan. 6, 2022 GMT to 8:00AM , Feb. 28, 2022 GMT - We will require a confidentiality agreement, if necessary, and interview with our researcher. We will discuss the proposed research and framework for the following contract and make a selection based on the content of the discussion. The selection process will take approximately 2 months, and we will inform you of the results after the selection. For research projects selected at the 2nd selection, a collaboration agreement will be negotiated between the research facility to which the researcher belongs and Asahi Kasei Pharma. Once a contract is concluded collaborative research can start. (1) Please provide only non-confidential information when submitting an application. (2) You may simultaneously submit research proposals to other companies, or apply for research grants or research funding to a public or private-sector body or organization, but if your proposal has already been selected elsewhere, please inform us before submitting the application, as we may choose to exclude your proposal from selection for this reason. (3) Please note that we will not select a research proposal that has already been selected by another company for joint research. (4) We will not use any of the materials and information received with research proposals and during the application process for any purpose other than this selection process.
Contact interne ULB :	Patrick Di Stefano
	9656
	patrick.di.stefano@ulb.be
Contact externe :
	https://www.asahikasei-pharma.co.jp/a-compass/en/#concept
Vous souhaitez recevoir de l’information destinée à quel type de profil :	Chercheurs
Discipline(s) scientifique(s) de l’appel :	Médecine, Pharmacie, Sciences biomédicales

Une question sur une fiche Infofin ? Contactez le contact interne ULB en charge du programme et/ou le contact externe lié à l'organisme en question.

Footer infofin